前列腺癌转移的临床试验
总计56398个结果
-
Astellas Pharma Europe B.V.Medivation, Inc.完全的
-
Astellas Pharma Global Development, Inc.Medivation, Inc.终止
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)未知
-
Institut Paoli-CalmettesNovartis终止
-
Rahul AggarwalSanofi完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Oregon Health and...完全的
-
Astellas Pharma Global Development, Inc.Medivation, Inc.撤销
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker 和其他合作者招聘中
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.完全的
-
Memorial Sloan Kettering Cancer Center主动,不招人
-
Shanghai Humantech Biotechnology Co. LtdShanghai Changhai Hospital,The First Affiliated Hospital of Naval Medical University招聘中
-
UNICANCERBayer招聘中
-
Azienda Ospedaliero-Universitaria Careggi完全的
-
Sanofi完全的前列腺癌转移英国, 奥地利, 比利时, 捷克语, 法国, 德国, 希腊, 冰岛, 爱尔兰, 意大利, 荷兰, 挪威, 西班牙
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.完全的
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.完全的
-
Astellas Pharma Global Development, Inc.Medivation, Inc.批准上市
-
Duke UniversityUnited States Department of Defense完全的
-
Tulane UniversityBlue Earth Diagnostics完全的
-
National Cancer Institute, Naples主动,不招人
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.未知转移性去势抵抗性前列腺癌
-
Ipsen终止转移性去势抵抗性前列腺癌法国, 西班牙, 波兰, 比利时, 德国, 意大利, 丹麦, 立陶宛, 英国, 捷克语, 匈牙利
-
Gustave Roussy, Cancer Campus, Grand ParisSanofi未知
-
The Christie NHS Foundation TrustAstraZeneca完全的
-
Suzhou Kintor Pharmaceutical Inc,完全的
-
AstraZeneca完全的转移性去势抵抗性前列腺癌印度, 秘鲁, 沙特阿拉伯, 埃及, 哥伦比亚, 大韩民国, 火鸡, 阿拉伯联合酋长国
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR)尚未招聘癌症 | 前列腺癌 | 转移癌 | 转移性前列腺癌
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Puma Biotechnology, Inc.撤销